A phase II study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma. Morschhauser F, Feugier P, Flinn IW, Gasiorowski R, et al. Blood 2020 Sep 21. pii: 463804. doi: 10.1182/blood.2020006578.

Read + Share

Amedeo Smart

Independent Medical Education

Morschhauser F, Feugier P, Flinn IW, Gasiorowski R, et al. A phase II study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma. Blood 2020 Sep 21. pii: 463804. doi: 10.1182/blood.2020006578.
PMID: 32959049